| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |